Immunoids: Building immunocompetent organoids from human pluripotent stem cells.

Immunoids incorporating mature and immature immune populations are emerging as vital models for studying human immune-tissue interactions.

• Why it matters: Understanding immune-tissue interactions is crucial for advancing disease research and developing targeted therapies, but standardized methods for creating functional immunoids are lacking.
• What they did: Researchers are developing immunoids from human pluripotent stem cells that include multilineage immune components and support endogenous immune co-development, aiming to establish fabrication standards.
• The result: These immunoids are expected to enhance physiological modeling, facilitate insights into human development and disease, and serve as foundational tools in precision medicine.